From: Fibrinogen: a novel predictor of responsiveness in metastatic melanoma patients treated with bio-chemotherapy: IMI (italian melanoma inter-group) trial
Variable
Hazard Ratio
IC 95% Hazard ratio
P
Liver Disease (yes vs no)
1.68
1.025–2.75
0.04
LDH (high vs normal)
1.89
1.17–3.06
0.009
Fibrinogen (high vs normal)
1.99
1.24–3.19
0.004